Is UnitedHealth Group (UNH) a Buy Right Now?
A plain-English read on UnitedHealth Group stock — what the chart and the numbers are saying today, with no jargon and no hype.
What this means, in plain English
UnitedHealth Group is currently priced at $395.62. While the stock moved down 1.52% today, it remains above its 200-day average of $352.68. This 200-day average is a long-term trend line that helps investors see if a stock is generally moving in a positive direction over time.
The RSI, or Relative Strength Index, is currently 36. This is a gauge of whether a stock has climbed too far, too fast; a number below 40 often suggests the stock is not currently overheated. With a P/E ratio of 25.4, we can see the price relative to the company's earnings.
Should you buy UnitedHealth Group stock?
The data suggests a buy because the price is holding above its long-term floor. Always remember that markets fluctuate, so consider your own timeline before adding this to your portfolio.
Is UNH a good stock for beginners?
UNH is a massive company that acts as a core pillar of the healthcare sector. Because it is a large, established business, it can be a steady choice for beginners, though you should always expect some volatility as prices move between the $391.43 floor and $431.68 ceiling.
What's driving UNH right now
The stock is currently finding stability near its recent support level of $391.43.
The price remains above the 200-day average of $352.68, indicating a steady historical direction.
The current price of $395.62 sits below the 50-day average of $417.7, which investors watch for momentum shifts.
The stock experienced a 1.52% decline today, reflecting the natural daily movement of the market.
What UnitedHealth Group actually does
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
UnitedHealth Group by the numbers
Wall Street consensus on UNH is Buy. That is the analyst community's view, shown for context — it is not our read and not a recommendation.
Who owns UnitedHealth Group?
Institutions — pension funds, asset managers, index providers — hold 90.5% of UNH, and the concentration matters: the largest single holder alone controls 8.56% of the company.
| Holder | Shares | % held |
|---|---|---|
| 76.86M | 8.56% | |
| 59.31M | 6.61% | |
| 45.63M | 5.08% |
Names withheld — plus 3 more records not shown.
See who owns itWhat UnitedHealth Group insiders have been doing
Executives and directors must disclose their own trades in company stock. Of the last 6 disclosed transactions we hold for UnitedHealth Group, 1 was a sale and 0 were open-market purchases; the other 5 were awards, vesting or option exercises rather than a decision to buy or sell. Insiders sell for many ordinary reasons — scheduled plans, tax, diversification — so a sale is not by itself a signal.
| Insider | Date | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-05 | SELL | 500 | $205.0K | |
| 2026-07-01 | AWARD / VEST | 220 | — | |
| 2026-07-01 | AWARD / VEST | 220 | — |
Names withheld — plus 3 more records not shown.
See which insidersThe numbers behind the read
Who in Washington has been trading UNH?
Members of Congress must disclose trades over $1,000 within 45 days under the STOCK Act. At least 25 disclosures name UNH — filed by 10 separate members or more and worth $414K–$1.14M combined (filings report bands, never exact amounts). 15 purchase-side, 10 sale-side, most recently on 2026-07-10.
| Member | Date | Action | Amount filed |
|---|---|---|---|
| 2026-07-10 | SELL | $1,001 - $15,000 | |
| 2026-06-12 | SELL | $1,001 - $15,000 | |
| 2026-06-12 | SELL | $1,001 - $15,000 |
Names withheld — plus 22 more records not shown.
See which membersUnitedHealth Group is a buy because it is trading near its support level while maintaining a healthy long-term upward trend.
Don't guess. Practice this trade first.
Buy it with virtual cash and watch how it plays out — before a dollar of your own is on the line.
Practice UNH risk-free in your paper portfolioPaper trading, the AI Read & live indicators are inside a Money GPS membership — one price, the whole platform.
Beginner questions about UNH
Should I buy UNH stock?+
The stock is a buy as it holds above the $352.68 long-term average despite a 1.52% daily dip.
Is UNH a good long-term investment?+
With the price currently above the 200-day average of $352.68, the stock shows a consistent long-term trend.
Is UNH a buy or a sell?+
Based on the current RSI of 36 and its position near the $391.43 support level, the indicator points to a buy.
Is UNH overvalued?+
The P/E ratio is 25.4, and the stock is currently trading well within its 52-week range of $255.97 to $461.62.
Is UNH a good stock for beginners?+
As a large company trading near its $391.43 support, it offers a stable entry point for those learning to invest.
Important disclaimer
This page is for educational and informational purposes only and is not financial, investment, tax, or legal advice, nor a recommendation, offer, or solicitation to buy, sell, or hold UnitedHealth Group (UNH) or any other security. The Money GPS is not a registered investment adviser, broker-dealer, or financial planner, and no content here should be relied upon to make an investment decision.
The verdict, indicators, and commentary are generated automatically — in part using AI — from third-party market data (via Yahoo Finance) that may be delayed, incomplete, or inaccurate, and is provided “as is” without any warranty. Figures reflect the market as of 2026-08-17 and change constantly; the read above may already be out of date. A “Buy,” “Hold,” or “Be Careful” label is a simplified, rules-based signal for beginners — not a price target or a guarantee of any outcome.
All investing involves risk, including the possible loss of your entire principal. Past performance and historical patterns do not guarantee future results. Always do your own research and consult a licensed financial professional who knows your personal circumstances before investing. You are solely responsible for your own investment decisions. The Money GPS and its authors may hold positions in the securities discussed and accept no liability for any loss arising from the use of this information.